Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ATTR
Pharma
BridgeBio CEO shrugs off recent Attruby pricing pressure fears
BridgeBio has laid out its expectations on potential generic pricing pressure for Attruby and provided more evidence of the drug's strong launch.
Kevin Dunleavy
Feb 25, 2026 2:30pm
Alnylam hits profitability in Q4 despite Amvuttra revenue miss
Feb 12, 2026 11:05am
AZ sets sights on 25+ blockbusters by 2030
Feb 10, 2026 11:20am
BridgeBio shares slide on Pfizer's ATTR patent withdrawal
Feb 6, 2026 10:50am
AZ's $80B revenue target 'very much within reach,' CFO says
Jan 14, 2026 10:00am
Pfizer's challenge of BridgeBio ads referred to federal agencies
Nov 10, 2025 11:15am
